To evaluate the effects of autologous adipose tissue-derived mesenchymal stem cell (MSC) transplantation on chronic pain and comorbid atopic dermatitis in a patient with a history of ineffective standard treatments.
Asthma attacks ceased after MSC treatment, with a notable reduction in inhaled steroid use.
Serum levels of SDF1 and VEGF increased by approximately 30% after MSC transplantation, suggesting a biological response.
Interpretation:
The case suggests that MSC therapy may effectively reduce symptoms of allergic diseases, including atopic dermatitis and asthma, potentially through mechanisms involving inflammation suppression and vascular permeability reduction, warranting further exploration.
Limitations:
Single case study limits generalizability of findings.
No control group or long-term follow-up data beyond 6 months.
Lack of diverse patient demographics may affect the applicability of findings.
Conclusion:
Autologous MSC transplantation may be a promising treatment for patients with atopic dermatitis and asthma, warranting further research, including randomized controlled trials, to identify effective markers and mechanisms.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
